Werewolf Therapeutics, Inc. (HOWL) — Dilution Risk Analysis
Current Snapshot
Werewolf Therapeutics, Inc. (HOWL) has a DilutionWatch score of 50/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 50/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 8-K 1, 4 5, SC 13D/A 3, XBRL 1.
| Form | Filed | Accession |
|---|---|---|
| 8-K | 2026-08-21 | 0001193125-26-360059 |
| 4 | 2026-07-08 | 0001134657-26-000020 |
| SC 13D/A | 2026-07-02 | 0001346824-26-000187 |
| SC 13D/A | 2026-06-26 | 0001346824-26-000185 |
| 4 | 2026-06-22 | 0001231919-26-000688 |
| SC 13D/A | 2026-06-22 | 0001346824-26-000180 |
| 4 | 2026-06-16 | 0001231919-26-000654 |
| 4 | 2026-06-11 | 0001231919-26-000628 |
| 4 | 2026-06-10 | 0001134657-26-000018 |
| xbrl | 2021-12-31 | xbrl-6287-xbrl_convertible |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 4 months | Source |
| Three-year share count growth | 34.28% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 50/10) Source
- Cash Runway
- 4 months Source
- Share Count Growth (3-Year)
- 34.28% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.